$BON

Bon Natural Life Ltd

CIK:0001816815|SEC Filings

Consolidated Statements of (Loss) Income and Comprehensive (Loss) Income - USD ($)	12 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
REVENUE	$ 18,670,684	$ 23,844,556	$ 29,522,353
COST OF REVENUE	(14,791,863)	(16,734,547)	(20,682,326)
GROSS PROFIT	3,878,821	7,110,009	8,840,027
OPERATING EXPENSES
Selling expenses	(436,933)	(270,579)	(293,719)
General and administrative expenses	(4,310,910)	(3,345,240)	(2,311,378)
Research and development expenses	(754,193)	(1,620,656)	(298,469)
TOTAL OPERATING EXPENSES	(5,502,036)	(5,236,475)	(2,903,566)
(LOSS) INCOME FROM OPERATIONS	(1,623,215)	1,873,534	5,936,461
OTHER INCOME (EXPENSES)
Interest income	867	393	9,414
Interest expense	(366,180)	(303,255)	(238,168)
Government subsidiaries	37,256	63,450	25,415
Gain (loss) on disposal of subsidiaries	160,927
Other income (expenses)	80,328	(918,183)	(160,255)
TOTL OTHER EXPENSES, NET	(86,802)	(1,157,595)	(363,594)
INCOME BEFORE INCOME TAX PROVISION	(1,710,017)	715,939	5,572,867
INCOME TAX PROVISION	339,414	351,179	1,002,298
NET (LOSS) INCOME FROM CONTINUING OPERATIONS	(2,049,431)	364,760	4,570,569
Net loss from the sale of the Gansu subsidiary		(19,512)	(17,887)
NET (LOSS) INCOME	(2,049,431)	345,248	4,552,682
Less: net loss attributable to non-controlling interest	(54,663)	(52,924)	(43,300)
NET (LOSS) INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED	(1,994,768)	398,172	4,595,982
OTHER COMPREHENSIVE (LOSS) INCOME
Total foreign currency translation adjustment	(298,871)	1,102,618	(1,040,285)
TOTAL COMPREHENSIVE (LOSS) INCOME	(2,348,302)	1,447,866	3,512,397
Less: comprehensive loss attributable to non-controlling interest	(55,381)	(54,333)	(33,311)
COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO BON NATURAL LIFE LIMITED	$ (2,292,921)	$ 1,502,199	$ 3,545,708
(LOSS) EARNINGS PER SHARE
Basic	$ (0.72)	$ 4.17	$ 125.72
Diluted	$ (0.72)	$ 4.14	$ 124.92
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING
Basic	2,755,232	95,513	36,558
Diluted	2,755,232	96,114	36,792

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net (loss) income	$ (2,049,431)	$ 345,248	$ 4,552,682
Less: net loss from discontinued operations		(19,512)	(17,887)
NET (LOSS) INCOME FROM CONTINUING OPERATIONS	(2,049,431)	364,760	4,570,569
Adjustments to reconcile net (loss) income to cash provided (used in) operating activities:
Allowance for doubutful accounts	693,822	1,000,000
Depreciation and amortization	1,087,635	1,107,360	949,550
Inventory reserve (recovery)	432,765	(990)	(5,812)
Deferred income tax			1,411
Amortization of operating lease right-of-use assets	198,378	170,172	228,552
Share-based compensation	1,393,573	1,319,840	349,396
(Gain) loss on disposal of subsidiaries	(160,927)
Changes in operating assets and liabilities:
Accounts receivable	(108,814)	(6,814,746)	2,081,376
Inventories	(2,165,615)	(530,637)	721,371
Advance to supplies, net	(1,668,615)	(5,586,209)	(4,563,346)
Prepaid expenses and other current assets	(11,736,318)	(7,400,216)	(2,170,541)
Accounts payable	6,107,669	1,917,735	833,547
Operating lease liabilities	(32,952)		(232,147)
Taxes payable	1,268,173	832,476	1,561,946
Deferred revenue	(276,248)	385,769	(80,176)
Accrued expenses and other current liabilities	7,158,020	5,525,631	2,097,424
Net cash provided by (used in) operating activities from continuing operations	141,115	(7,709,055)	6,343,120
Net cash used in operating activities from discontinued operations		(14,649)	(6,960,024)
Net cash provided by (used in) operating activities	141,115	(7,723,704)	(616,904)
Cash flows from investing activities
Purchase of short-term investments			(67)
Proceeds upon redemption of short-term investments		65
Purchase of property and equipment	(6,827)	(7,047)	(61,906)
Proceeds from sales of property and equipment
Capital expenditure on construction-in-progress	(4,364,757)
Purchase of intangible assets	(5,624,354)		(669,190)
Proceeds of borrowings to related parties			5,623
Net cash used in investing activities from continuing operations	(9,995,938)	(6,982)	(725,540)
Net cash used in investing activities from discontinued operations		(8,745)	(460,125)
Net cash used in investing activities	(9,995,938)	(15,727)	(1,185,665)
Cash flows from financing activities
Net proceeds from issuance of ordinary shares	10,672,912	5,600,000	2,027,544
Proceeds from short-term loans	12,020,797	4,308,260	2,879,809
Proceeds from long-term loans	970,537	694,030	1,132,803
Repayment of short-term loans	(7,290,399)	(1,510,029)	(2,728,836)
Repayment of long-term loans	(340,102)	(451,269)	(2,143,046)
Proceeds from (repayment of) borrowings from related parties	(578,942)	205,190	10,419
Proceeds from (repayment of) third party loans		(96,066)
Proceeds from (repayment of) finance lease			(26,509)
Net cash provided by financing activities from continuing operations	15,454,803	8,750,116	1,152,184
Net cash provided by financing activities from discontinued operations		4,997	3,063
Net cash provided by financing activities	15,454,803	8,755,113	1,155,247
Effect of changes of foreign exchange rates on cash	7,388	(469,823)	(80,788)
Net increase (decrease) in cash and restricted cash	5,607,368	545,859	(728,110)
Cash and restricted cash, beginning of year	658,610	112,751	840,861
Cash and restricted cash, end of year	6,265,978	658,610	112,751
Less: cash of discontinued operations, end of year		1,405	1,517
Cash and restricted cash of the continued operations at the end of the year	6,265,978	657,205	111,235
Supplemental disclosure of cash flow information
Cash paid for interest expenses	324,026	303,325	238,224
Cash paid for income taxes			478,683
Supplemental disclosure of non-cash investing and financing activities
Exercise of options			2
Right-of-use assets obtained in exchange for operating lease obligations
Unpaid purchase of property and equipment			403,318
Cash, cash equivalents, and restricted cash	$ 6,265,978	$ 657,205

Consolidated Balance Sheets	Sep. 30, 2025 USD ($)	Sep. 30, 2024 USD ($)
CURRENT ASSETS
Cash	$ 3,765,978	$ 80,466
Restricted cash	2,500,000	576,739
Accounts receivable, net	11,012,741	11,781,103
Inventories, net	3,305,438	1,572,224
Advances to suppliers, net	15,938,109	14,469,299
Due from related parties	527,389	33,228
Prepaid expenses and other current assets	8,710,796	4,296,949
Current assets held for sale associated with the sale of the Gansu subsidiary		6,983,849
TOTAL CURRENT ASSETS	45,760,451	39,793,857
NON-CURRENT ASSETS
Property, plant and equipment, net	18,158,289	15,005,686
Intangible assets, net	6,424,893	776,995
Right-of-use lease assets, net	113,250	141,895
Non-current other receivables	14,728,732
Deferred tax assets, net		1,388
Non-current assets held for sale associated with the sale of the Gansu subsidiary		6,045,611
TOTAL NON-CURRENT ASSETS	39,425,164	21,971,575
TOTAL ASSETS	85,185,615	61,765,432
CURRENT LIABILITIES
Short-term loans	10,248,225	5,719,493
Current portion of long-term loans	1,081,613	461,765
Accounts payable	7,641,274	3,428,102
Due to related parties	134,073	244,871
Taxes payable	4,881,898	3,681,166
Deferred revenue	219,678	506,769
Accrued expenses and other current liabilities	2,024,902	2,243,219
Operating lease liabilities, current	76,797	148,904
Current liabilities held for sale associated with the sale of the Gansu subsidiary		11,543
TOTAL CURRENT LIABILITIES	26,308,460	16,445,832
NON-CURRENT LIABILITIES
Long-term loans	842,815	970,061
Operating lease liability, non-current	36,601
TOTAL NON-CURRENT LIABILITIES	879,416	970,061
TOTAL LIABILITIES	27,187,876	17,415,893
SHAREHOLDERS’ EQUITY
Additional paid-in capital	40,791,764	25,005,100
Statutory reserve	2,849,440	2,733,354
Retained earnings	16,630,831	18,741,685
Accumulated other comprehensive (loss)	(2,875,571)	(2,577,418)
TOTAL BON NATURAL LIFE LIMITED SHAREHOLDERS’ EQUITY	57,550,680	43,906,691
NON-CONTROLLING INTEREST	447,059	442,848
TOTAL SHAREHOLDERS’ EQUITY	57,997,739	44,349,539
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	85,185,615	61,765,432
Common Class A [Member]
SHAREHOLDERS’ EQUITY
Ordinary shares	152,174	1,928
Common Class B [Member]
SHAREHOLDERS’ EQUITY
Ordinary shares	$ 2,042	$ 2,042